Clinical Trials Using Romiplostim
Clinical trials are research studies that involve people. The clinical trials on this list are studying Romiplostim. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Romiplostim in Treating Patients with Chemotherapy-Induced Thrombocytopenia
This phase II trial studies how well romiplostim works in treating patients with chemotherapy-induced thrombocytopenia. Platelets are cells in the blood that help the blood to clot. Thrombocytopenia refers to a low platelet count and can increase the risk of bleeding. It is a common side effect of chemotherapy and can delay treatment. Romiplostim may help improve platelet counts in patients with chemotherapy-induced thrombocytopenia.
Location: 6 locations
Romiplostim in Treating Patients with Slow Platelet Recovery after Umbilical Cord Blood Transplant
This phase I trial studies the side effects and best dose of romiplostim in treating patients with slow platelet recovery after umbilical cord blood transplant. Romiplostim may help increase and maintain platelet counts in patients whose platelet counts have not recovered after umbilical cord blood transplant.
Location: University of Minnesota / Masonic Cancer Center, Minneapolis, Minnesota